Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1995 1
1996 1
1999 2
2004 1
2007 2
2010 2
2012 1
2013 2
2015 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Childhood myelodysplastic syndrome.
Chatterjee T, Choudhry VP. Chatterjee T, et al. Indian J Pediatr. 2013 Sep;80(9):764-71. doi: 10.1007/s12098-013-1130-8. Epub 2013 Aug 3. Indian J Pediatr. 2013. PMID: 23912822 Review.
The most effective and curative treatment is Hematopoietic stem cell transplantation and this is particularly effective in children with the monosomy 7 genetic defect as well as those displaying complex karyotype abnormalities provided it is instituted early in the course …
The most effective and curative treatment is Hematopoietic stem cell transplantation and this is particularly effective in children with the …
The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).
Hasle H, Baumann I, Bergsträsser E, Fenu S, Fischer A, Kardos G, Kerndrup G, Locatelli F, Rogge T, Schultz KR, Starý J, Trebo M, van den Heuvel-Eibrink MM, Harbott J, Nöllke P, Niemeyer CM; European Working Group on childhood MDS. Hasle H, et al. Leukemia. 2004 Dec;18(12):2008-14. doi: 10.1038/sj.leu.2403489. Leukemia. 2004. PMID: 15496981
The International Prognostic Scoring System (IPSS) for myelodysplastic syndrome (MDS) is based upon weighted data on bone marrow (BM) blast percentage, cytopenia, and cytogenetics, separating patients into four prognostic groups. ...
The International Prognostic Scoring System (IPSS) for myelodysplastic syndrome (MDS) is based upon weighted data on bone marrow (BM) …
Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
Hama A, Takahashi Y, Muramatsu H, Ito M, Narita A, Kosaka Y, Tsuchida M, Kobayashi R, Ito E, Yabe H, Ohga S, Ohara A, Kojima S. Hama A, et al. Haematologica. 2015 Nov;100(11):1426-33. doi: 10.3324/haematol.2015.128553. Epub 2015 Aug 13. Haematologica. 2015. PMID: 26273061 Free PMC article. Clinical Trial.
Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome.
Göhring G, Michalova K, Beverloo HB, Betts D, Harbott J, Haas OA, Kerndrup G, Sainati L, Bergstraesser E, Hasle H, Stary J, Trebo M, van den Heuvel-Eibrink MM, Zecca M, van Wering ER, Fischer A, Noellke P, Strahm B, Locatelli F, Niemeyer CM, Schlegelberger B. Göhring G, et al. Blood. 2010 Nov 11;116(19):3766-9. doi: 10.1182/blood-2010-04-280313. Epub 2010 Aug 27. Blood. 2010. PMID: 20802024 Free article. Clinical Trial.
To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluated with regard to karyo …
To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 c …
Childhood myelodysplastic syndromes with 11p15 translocation.
Inaba T, Hayashi Y, Hanada R, Nakashima M, Yamamoto K, Nishida T. Inaba T, et al. Cancer Genet Cytogenet. 1988 Aug;34(1):41-6. doi: 10.1016/0165-4608(88)90166-5. Cancer Genet Cytogenet. 1988. PMID: 3293771 Review.
The first case, with inv(11)(p15q23), had a complex clinical course; the initial diagnosis was aplastic anemia, then refractory anemia with excess of blasts in transformation (RAEB-t), and finally, before death, chronic myelomonocytic leukemia with hematologic features sim …
The first case, with inv(11)(p15q23), had a complex clinical course; the initial diagnosis was aplastic anemia, then refractory anemi …
Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia.
Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N, Jacobsen BB. Hasle H, et al. Leukemia. 1996 Aug;10(8):1269-73. Leukemia. 1996. PMID: 8709630 Clinical Trial.
Duration of treatment-related cytopenia was similar in MDS and AML, except for a longer period of leukopenia in MDS following the second course of induction. Seven of 10 MDS children receiving BMT without prior chemotherapy are long-term survivors. ...
Duration of treatment-related cytopenia was similar in MDS and AML, except for a longer period of leukopenia in MDS following the second …
14 results